"Designing Growth Strategies is in our DNA"

Preeclampsia Therapeutics Market Size, Share & Industry Analysis, By Preeclampsia Type (Mild Preeclampsia, Severe Preeclampsia), By Drug Class (Antihypertensive Agents, Anticonvulsants, Antioxidants, Others) and Regional Forecast, 2021-2028

Region : Global | Report ID: FBI101516 | Status : Ongoing

 

KEY MARKET INSIGHTS

According to the National Institutes of Health (NIH), in 2016, an estimated 5.0-8.0% of pregnant women were affected by preeclampsia globally. The condition of preeclampsia occurs when a pregnant woman suffers from high blood pressure. The condition occurs after 20th week of pregnancy. There are two types of preeclampsia, mild preeclampsia, and severe preeclampsia.


Certain factors such as genetic disorders, blood vessels problems, autoimmune disorders, and weak immune system cause condition of preeclampsia. Preeclampsia shows symptoms such as sudden gain or loss of weight, high amount of protein in urine, high blood pressure, and abdominal pain. Preeclampsia is responsible for increased prevalence of premature births.  According to preeclampsia foundation, globally, an estimated 20.0% of premature births are caused due to preeclampsia each year.


To gain extensive insights into the market, Request for Customization


Global preeclampsia therapeutics market growth is prominently being driven by the growing prevalence of preeclampsia. According to National Centre for Biotechnology Information (NCBI), preeclampsia is one of the prominent leading cause for maternal and fetal mortality.


Moreover, rise in risk factors for condition of preeclampsia such as obesity, diabetes, high blood pressure and increasing prevalence of genetic disorders projects growth in prevalence of preeclampsia, which will eventually increase the demand for preeclampsia therapeutics during forecast period. However, certain side effects of drugs for preeclampsia such as headache, nausea, and somnolence, also lack of healthcare infrastructure in emerging nations are restraining factors for growth of the global preeclampsia therapeutics market.  


However, certain side effects of drugs for preeclampsia such as headache, nausea, and somnolence, also lack of healthcare infrastructure in emerging nations are restraining factors for growth of the global preeclampsia therapeutics market.


Key Players Covered


The major companies covered in the global preeclampsia therapeutics market report include Sera Prognostics, Inc., DRG INSTRUMENTS GMBH, F. Hoffmann-La Roche Ltd., PerkinElmer Inc., AMAG Pharmaceuticals, A1M Pharma AB, LFB S.A.,VG Life sciences, Inc., Pluristem Therapeutics Inc., and others.


Segmentation






















 ATTRIBUTE


 DETAILS

By Preeclampsia Type




  • Mild Preeclampsia

  • Severe Preeclampsia



By Drug Class




  • Antihypertensive Agents

  • Anticonvulsants

  • Antioxidants

  • Others



By Geography




  • North America (USA and Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico and Rest of Latin America)

  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



As per the current preeclampsia therapeutics market trends, antihypertensive agents among drug class segment is expected to hold a higher share of the market as it is highly prescribed drug type for the treatment of preeclampsia.


Key Insights



  • Prevalence of preeclampsia for key countries

  • Pipeline Analysis

  • Reimbursement scenario for key countries

  • Key mergers and acquisitions


Regional Analysis


The global preeclampsia therapeutics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global preeclampsia therapeutics market during the forecast period owing to the rise in prevalence of preeclampsia. According to Preeclampsia Foundation, the rate of preeclampsia grew by an estimated 25.0% during past two decades in the U.S. alone. In Europe, rise in certain risk factors such as obesity, high blood pressure, and diabetes can lead to increase in prevalence of preeclampsia, which offers high opportunity for growth of the Europe preeclampsia therapeutics market. Asia Pacific and Middle East & Africa hold huge potential for growth of the global preeclampsia therapeutics market owing rapidly growing prevalence of preeclampsia.


Preeclampsia Therapeutics Industry Developments



  • In April 2019, NHS announced proposed plan to launch an advanced blood test which can speed up the diagnosis of preeclampsia. The new test enables the authority to boost the treatment program for preeclampsia.

  • In January 2017, Sera Prognostics signed a strategic agreement with Laboratory Corporation of America Holdings with an aim to expand its preeclampsia treatment product portfolio among extended geographical regions. 


Preeclampsia Therapeutics Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2020
  • 2017-2019

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Ansell
Fresenius
Jubilant
uniliver
abbvie

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X